GlassScriptPhysician profile
Rafael E Garcia-Ocasio
NPI 1356775530
$4,608.02
in general payments reported to CMS, 2019-2025
23 companies · $487 in 2025
The $487 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $182 · 2021: $301 · 2022: $328 · 2023: $2,718 · 2024: $409 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,191 · Food and Beverage: $1,207 · Travel and Lodging: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,190.97 |
| Food and Beverage | $1,207.25 |
| Travel and Lodging | $215.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,406.95 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $564.96 | 2019-2024 | |
| Astellas Pharma US INC | $299.13 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $172.57 | 2022-2025 | |
| Pfizer INC. | $152.89 | 2019-2024 | |
| Boston Scientific Corporation | $134.35 | 2024 | |
| Hologic Sales and Service, LLC | $103.90 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Avion Pharmaceuticals | $96.62 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $83.99 | 2019 | |
| Allergan, INC. | $75.50 | 2019-2020 | |
| Coopersurgical, INC. | $74.05 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Millicent US INC | $64.60 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Sumitomo Pharma America, INC. | $56.44 | 2023-2025 | Gemtesa, Myfembree |
| Organon LLC | $56.10 | 2022-2025 | Nexplanon |
| Integra Lifesciences Corporation | $47.73 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $43.30 | 2023 | Stratafix |
| Therapeuticsmd, INC. | $42.25 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $38.79 | 2019-2021 | |
| Smith+Nephew, INC. | $24.31 | 2024 | Pico 14 |
| Vertex Pharmaceuticals Incorporated | $21.25 | 2025 | |
| Organogenesis INC. | $17.27 | 2024 | Nushield |
| Exeltis, USA INC. | $16.51 | 2023 | Slynd |
| Exact Sciences Corporation | $14.56 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Garcia-Ocasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.